Skip to main content

Table 2 Characteristics of included guidelines

From: Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines

Characteristic

Condition (n, %)

Guidelines (n, %)

Arthritis

Asthma

Colorectal cancer

Depression

Diabetes

Heart failure

Stroke

Organization

 Professional society

7 (46.7)

4 (50.0)

6 (75.0)

2 (25.0)

18 (62.1)

14 (37.8)

10 (47.6)

61 (48.4)

 Government agency

6 (40.0)

1 (12.5)

2 (25.0)

3 (37.5)

7 (24.1)

5 (13.5)

4 (19.0)

28 (22.2)

 Disease foundation

–

–

–

–

–

14 (37.8)

3 (14.3)

17 (13.5)

 Non-profit agency

–

2 (25.0)

–

1 (12.5)

3 (10.3)

–

3 (14.3)

9 (7.1)

 Academic institution

–

1 (12.5)

–

2 (25.0)

1 (3.4)

4 (10.8)

1 (4.8)

9 (7.1)

 Expert panel

2 (13.3)

–

–

–

–

–

–

2 (1.6)

Country

 United States

7 (46.7)

4 (50.0)

6 (75.0)

4 (50.0)

19 (65.5)

27 (73.0)

9 (42.9)

76 (60.3)

 United Kingdom

5 (33.3)

3 (37.5)

1 (12.5)

2 (25.0)

5 (17.2)

6 (16.2)

5 (23.8)

27 (21.4)

 Canada

2 (13.3)

–

1 (12.5)

–

3 (10.3)

–

3 (14.3)

9 (7.1)

 Australia

–

–

–

1 (12.5)

1 (3.4)

–

3 (14.3)

5 (4.0)

 International group

–

1 (12.5)

–

–

–

1 (2.7)

1 (4.8)

3 (2.4)

 Finland

–

–

–

–

1 (3.4)

2 (5.4)

–

3 (2.4)

 Spain

1 (6.7)

–

–

–

–

–

–

1 (0.8)

 Singapore

–

–

–

1 (12.5)

–

–

–

1 (0.8)

 Brazil

–

–

–

–

–

1 (2.7)

–

1 (0.8)

Total

15 (11.9)

8 (6.3)

8 (6.3)

8 (6.3)

29 (23.0)

37 (29.4)

21 (16.7)

126 (100.0)